Binge drinking more likely to cause death or liver problems in people with HIV


A recent Swiss study looked at mortality (death) and liver disease among people living with HIV by their drinking habits. Compared to all other drinking patterns, people living with HIV who reported binge drinking were more likely to die and more likely to experience liver problems. There was no difference in these outcomes for people with HIV who had non-hazardous drinking, or hazardous drinking without binge drinking.

According to the World Health Organization, around 5% of all global deaths were attributed to alcohol use in 2016. In Switzerland, the site of this study, an estimated one in ten deaths are due to alcohol misuse. Alcohol use is the second most common cause of end-stage liver disease (behind viral hepatitis) and is responsible for 30-40% of liver cirrhosis deaths in high income countries.

There is some evidence that drinking is more harmful to people living with HIV than those who don’t have HIV. While the risks associated with alcohol misuse in people living with HIV are well known, less is known about how different drinking habits (overall alcohol intake, frequency of drinking, and how much alcohol is consumed per occasion) affect these risks. This research adds to the growing evidence of how different drinking habits have different risks for liver problems and death, highlighting the importance of assessing drinking patterns in routine care.



Severe fibrosis, or scarring of organs. The structure of the organs is altered, and their function diminished. The term cirrhosis is often used in relation to the liver. 

representative sample

Studies aim to give information that will be applicable to a large group of people (e.g. adults with diagnosed HIV in the UK). Because it is impractical to conduct a study with such a large group, only a sub-group (a sample) takes part in a study. This isn’t a problem as long as the characteristics of the sample are similar to those of the wider group (e.g. in terms of age, gender, CD4 count and years since diagnosis).


A mental health problem causing long-lasting low mood that interferes with everyday life.

statistical significance

Statistical tests are used to judge whether the results of a study could be due to chance and would not be confirmed if the study was repeated. If result is probably not due to chance, the results are ‘statistically significant’. 


Lowest of a series of measurements. For example, an individual’s CD4 nadir is their lowest ever measured CD4 count.

This study is a part of the Swiss HIV Cohort Study, which is an ongoing, nationally representative study that includes nearly 80% of all people living with HIV in Switzerland who are receiving HIV treatment. People living with HIV who completed an alcohol use assessment and attended at least one follow-up visit between January 2013 and April 2020 were eligible for the study.

A total of 11,849 people were included in the study, with a median follow-up time of nearly seven years. The median age was 46, just under three-quarters of participants were male, and almost half of all study participants were gay men. Just over three-quarters of participants were White.

The study compared all-cause mortality and liver problems – such as cirrhosis, multiple abnormal lab results, and liver transplants – by peoples’ drinking habits. Using the Alcohol Use Disorder Identification Test (AUDIT-C), drinking habits were classified as:

  1. Abstinence: no drinking
  2. Non-hazardous drinking
  3. Hazardous, but not binge drinking
  4. Binge drinking.

An AUDIT-C score of ≥ 3 for women and ≥ 4 for men was considered hazardous drinking for this study. For example, a man who usually has four drinks on one occasion, and does so two or three times a week, would be classified as a hazardous drinker. Binge drinking was defined as consuming six or more drinks on one occasion more than once a month.

Participants had an average of 12 assessments each over the study period, so researchers classified their drinking habits by their most frequently reported response. Over half (58%) of participants had non-hazardous drinking, followed by abstinence (23%), hazardous but not binge drinking (15%), and binge drinking (4%). Of those reporting abstinence, a substantial number of people consistently reported abstinence during the entire study period, while a second group of people were abstinent for less than 20% of their follow-up time.

People with binge drinking habits were more likely to be White men, less likely to live with a partner, and had higher rates of depression during follow-up. Binge drinkers were also more likely to report injection drug use or smoking, lower educational attainment, and more likely to be unemployed. People reporting abstinence were more likely to be women, more likely to have had a lower nadir CD4 count and a history of AIDS-defining illnesses, and more likely than non-hazardous drinkers to be co-infected with viral hepatitis. All of these differences were highly significant (p < 0.001).

During the study period, 470 people died. The most common causes of death were non-AIDS cancer, including liver cancer (22%), cardiovascular (11%), HIV-related (5%), accidents (5%), and other infections (4%).

Compared to non-hazardous drinkers, binge drinkers had an increased risk for all-cause mortality (aIRR =1.9, 95%, CI 1.3-2.7). People reporting abstinence also had increased risk for all-cause mortality (aIRR =1.9, 95%, CI 1.5-2.3) and liver-related death (aIRR=3.9, 95%, CI 1.7-9.1), compared to non-hazardous drinkers.

A total of 239 people experienced a liver-related events during the study period, with 140 people diagnosed with cirrhosis. Rates of liver events were highest in people reporting binge drinking, followed by those reporting abstinence, hazardous drinking, and non-hazardous drinking.

After controlling for other factors, binge drinking remained strongly associated with liver-related events (aIRR = 3.8, 95%, CI 2.4-5.8). The researchers did not find a difference in outcomes among people with non-hazardous and hazardous drinking patterns.

People who were abstinent also had statistically significant increased risks of death and liver problems. This was not unexpected as it aligns with previous research findings. This could be because some people who are abstinent are former heavy drinkers, who would have more risk for liver problems than lifetime abstainers. It could also be that people with serious illnesses or pre-existing liver disease might be more likely to abstain from alcohol.

This study had similar outcomes to a recent population-level study in Finland that was not specific to people living with HIV. That study also found that binge drinking raised the risk for liver disease, even between people with similar overall levels of alcohol consumption. These findings are significant because they can inform how clinicians assess alcohol use and highlight the importance of discussing drinking patterns, not just overall alcohol consumption, in a healthcare setting.


Surial, B et al. The impact of binge drinking on mortality and liver disease in the Swiss HIV cohort study. Journal of Clinical Medicine 10: 295, 14 January 2021 (open access).

doi: 10.3390/jcm10020295